Loss of function experiments in pancreatic cancer cell lines demonstrated that HOXB6 and HOXB8 control cancer cell proliferation, viability, apoptosis, senescence, and sensitivity to gemcitabine. The gene discussed is HOXB6; the disease is pancreatic neoplasm.